Pharmacotherapy for obesity -- do the benefits outweigh the risks?

N Engl J Med. 1996 Aug 29;335(9):659-60. doi: 10.1056/NEJM199608293350910.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Appetite Depressants / adverse effects
  • Appetite Depressants / therapeutic use*
  • Fenfluramine / adverse effects
  • Fenfluramine / therapeutic use
  • Humans
  • Hypertension, Pulmonary / chemically induced*
  • Obesity / drug therapy*

Substances

  • Appetite Depressants
  • Fenfluramine